PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY
Raymond H. Chan(Beth Israel Deaconess Medical Center), Martin S. Maron(Beth Israel Deaconess Medical Center), C. Michael Gibson(Baim Institute for Clinical Research), Claudio Rapezzi(University of Ferrara), Ethan J. Rowin(Beth Israel Deaconess Medical Center), Thomas H. Hauser(Beth Israel Deaconess Medical Center), Camillo Autore(Sapienza University of Rome), Gabriele Egidy Assenza(Boston Children's Hospital), Iacopo Olivotto(Azienda Ospedaliero-Universitaria Careggi), Tammy S. Haas(Beth Israel Deaconess Medical Center), Benedetta Tomberli(Beth Israel Deaconess Medical Center), Barry J. Maron(Lahey Hospital and Medical Center), Paolo Spirito(University of Naples Federico II), John R. Lesser(Minneapolis Heart Institute Foundation), Evan Appelbaum(Harvard University Press), M. Susie Hong(Beth Israel Deaconess Medical Center), Elena Biagini, James E. Udelson(Tufts Medical Center), Carlo N. De Cecco(Emory Healthcare), Christiane Gruner(Zurich Heart House), Harry Rakowski(University Health Network), E. Francis Cook(Brigham and Women's Hospital), Warren J. Manning(Beth Israel Deaconess Medical Center), Francesco Formisano(Worcestershire Acute Hospitals NHS Trust), Andrew Crean(Stollery Children's Hospital)
Cited by 28
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k